Market Overview:
The global estrogen market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of estrogen deficiency, rising awareness about the benefits of estrogen therapy, and technological advancements in the field of hormone therapy. The global estrogen market by type is segmented into tablets and injections. The injection segment is expected to grow at a higher CAGR than the tablet segment during the forecast period. This can be attributed to the growing preference for injectable forms of hormones over oral forms, owing to their better absorption and longer duration of action. The global estrogen market by application is divided into hospitals, obstetrics & gynecology clinics, and others (including research institutes and home care settings). The hospitals segment accounted for the largest share in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to increasing number of surgical procedures performed in hospitals as well as rising incidence rates of various diseases that require hormonal treatment such as cancer and menopause-related symptoms.
Product Definition:
Estrogen is a hormone that is important for the development and function of female reproductive tissues. It also helps regulate other body processes such as bone density, heart health, and mood.
Tablets:
Tablets, it's usage.
The global estrogen market is expected to witness significant growth over the forecast period. Increasing prevalence of breast cancer & other female reproductive disorders along with growing awareness levels among women about their health are some factors attributing to the estimated growth.
Injection:
Injection is a medical procedure used to introduce the female hormone estrogen into the body. Estrogen is responsible for breast growth, vaginal lubrication, and helps in maintaining bone strength. In women who do not produce enough estrogen or have lost their natural source of estrogen due to illness or injury, it is recommended that they take an injection of estradiol (a type of estrogen) by a healthcare professional.
Application Insights:
The global estrogen market is segmented on the basis of application into hospitals, obstetrics and gynecology clinics, others. Hospitals were estimated to be the largest revenue generating segment in 2017. This large share can be attributed to a high usage rate of hormonal contraceptives by women which results in an increased demand for estradiol tablets and injections. Moreover, increasing awareness about HRT among menopausal women is expected to drive this application segment over the forecast period.
Obstetrics and gynecology clinics are anticipated to witness significant growth during the forecast period as these clinics provide medical services for female reproductive system disorders including polycystic ovary syndrome (PCOS), uterine cancer & fibroids etc., These factors are expected to increase product demand at a faster rate than other segments during the forecast period thus driving its overall market growth from 2018-2030 in terms of value as well as volume%.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure, awareness about early diagnosis, and availability of effective treatment methods are some factors attributing to its largest share. In addition, rising prevalence of osteoporosis is anticipated to fuel the demand for estradiol tablets in this region over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing government initiatives for improving women health as well as growing awareness among people regarding various available options such as HRT or hormone replacement therapy. Growing medical tourism industry due to lower treatment cost compared with western countries will also contribute toward higher demand for estradiol products in Asia Pacific over the next eight years.
Growth Factors:
- Increasing awareness about the benefits of estrogen therapy in post-menopausal women
- Rising prevalence of menopause and other estrogen-deficient conditions
- Growing demand for hormone replacement therapy (HRT) products
- Proliferation of targeted therapies and personalized medicine approaches for estrogen-related diseases
- Technological advancements in the development of novel HRT formulations
Scope Of The Report
Report Attributes
Report Details
Report Title
Estrogen Market Research Report
By Type
Tablets, Injection
By Application
Hospitals, Obstetrics & Gynecology Clinics, Others
By Companies
Pfizer, Teva Pharmaceuticals, Bayer, Xi'an Sgonek Biological Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Estrogen Market Report Segments:
The global Estrogen market is segmented on the basis of:
Types
Tablets, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Obstetrics & Gynecology Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Teva Pharmaceuticals
- Bayer
- Xi'an Sgonek Biological Technology
Highlights of The Estrogen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Injection
- By Application:
- Hospitals
- Obstetrics & Gynecology Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Estrogen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Estrogen is a type of hormone that helps to regulate the menstrual cycle, growth and development in women, and the production of breast milk.
Some of the key players operating in the estrogen market are Pfizer, Teva Pharmaceuticals, Bayer, Xi'an Sgonek Biological Technology.
The estrogen market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Estrogen Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Estrogen Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Estrogen Market - Supply Chain
4.5. Global Estrogen Market Forecast
4.5.1. Estrogen Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Estrogen Market Size (000 Units) and Y-o-Y Growth
4.5.3. Estrogen Market Absolute $ Opportunity
5. Global Estrogen Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Estrogen Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Injection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Estrogen Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Estrogen Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Obstetrics & Gynecology Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Estrogen Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Estrogen Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Estrogen Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Estrogen Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Estrogen Demand Share Forecast, 2019-2026
9. North America Estrogen Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Estrogen Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Estrogen Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Obstetrics & Gynecology Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Estrogen Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Injection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Estrogen Demand Share Forecast, 2019-2026
10. Latin America Estrogen Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Estrogen Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Estrogen Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Obstetrics & Gynecology Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Estrogen Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Injection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Estrogen Demand Share Forecast, 2019-2026
11. Europe Estrogen Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Estrogen Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Estrogen Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Obstetrics & Gynecology Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Estrogen Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Injection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Prouct Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Estrogen Demand Share, 2019-2026
12. Asia Pacific Estrogen Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Estrogen Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Estrogen Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Obstetrics & Gynecology Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Estrogen Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Injection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Estrogen Demand Share, 2019-2026
13. Middle East & Africa Estrogen Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Estrogen Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Estrogen Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Obstetrics & Gynecology Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Estrogen Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Injection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Estrogen Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Estrogen Market: Market Share Analysis
14.2. Estrogen Distributors and Customers
14.3. Estrogen Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Xi'an Sgonek Biological Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
